Xilinx, Inc. (NASDAQ:XLNX) rose 5.13% during previous trade. Credit Suisse issued rating on the stock of Xilinx, Inc. (NASDAQ:XLNX) in a research note issued to investors on Apr-24-17, the stock received “Upgrade” rating from Neutral to Outperform. Additionally Macquarie issued their verdict on the stock of the company, on record date of Mar-31-17 the stock was “Initiated” as Neutral at $60 besides that on Jan-18-17 Xilinx, Inc. (NASDAQ:XLNX) was “Downgraded” by Barclays from Equal Weight to Underweight from $48 to $53. Furthermore on Dec-15-16 the stock was “Upgraded” by Morgan Stanley from Equal Weight to Underweight.
Xilinx, Inc. (NASDAQ:XLNX) shares ended last trading session at the price of $60.65 whereas a number of traders indicating mean target price will hit $60.29 over the next twelve months, mean value of price target most recently revised on 04/19/17. Xilinx, Inc. (NASDAQ:XLNX)’s highest estimates of price target are $70 and low forecast is $45 based on the opinion of 21 analysts. The price target estimates represents a standard deviation of 7.22. However brokerage recommendations suggests an ABR of 2.75 based on calls of 18 experts, where 4 brokers polls the stock a Strong Buy, 1 suggest the stock a Buy, 10 suggest Hold, 1 are rating the stock as Sell while 2 as Strong Sell.
Xilinx, Inc. (NASDAQ:XLNX) is expected to release the earnings of its current quarter on 4/26/17 After Market Close. The company is expected to release $0.54 EPS for current quarter according to 22 analysts whereas the company reported $0.54 EPS during same quarter a year ago. For the current quarter the stock has lowest EPS estimates of $0.53 and high estimate of $0.56. For the current year Xilinx, Inc. (NASDAQ:XLNX) has set to release EPS of $2.28 as per the sentiments of 23 analysts, however according to 24 analysts, the company expected to release $2.41 EPS for next year.
Xilinx, Inc. (NASDAQ:XLNX)’s average revenue estimates for the current quarter are $605.24M according to 21 number of analysts. However its lowest revenue estimates are $604.1M and highest revenue estimates are $607.2M. A year ago the company’s sales were $571.07M. Its yearly sales growth estimates are 6%. For the next quarter the company has anticipated average revenues of $612.94M, according to the sentiments of 20 analysts. For the current year the company has fixed $2.34B revenues, as per the opinion of 23 analysts. For the current year the company has low revenue estimates of $2.34B in contradiction of high revenue estimates of $2.35B. Whereas for the next year revenues are set at $2.48B by 23 analysts.
The stock exchanged hands 7.58M shares versus average trading capacity of 2.47M shares, while its shares’ total market worth is $15.09B along with 248.93M outstanding shares. Xilinx, Inc. (NASDAQ:XLNX) shares were trading -2% below from the 52-week high price mark of $61.89 and +49.93% above from the 52-week price bottom of $40.45. However the company observed 52 week high price on 12/28/16 and witnessed 52 week low price on 04/28/16. The company’s price sits 3.92% above from its 50-day moving average of $58.07 and 11.37% far from the stock’s 200-day moving average which is $56.37. Xilinx, Inc. (NASDAQ:XLNX)’s price to sales ratio for trailing twelve month stands at 6.59, whereas its price to book ratio for most recent quarter sits at 6.13. However the company’s price to cash per share for most recent quarter stands at 4.68. Its price to free cash flow for trailing twelve months is 42.95.